Nab-paclitaxel, a nanoparticle albumin-bound form of paclitaxel, enhances drug delivery to tumors by targeting albumin receptors overexpressed on cancer cells, improving treatment precision and reducing side effects [83]. The gene discussed is ALB; the disease is cancer.